Skip to main content
SpringerLink
Log in

Das leistet die molekulare Allergiediagnostik

Schonend und hoch spezifisch

  • FORTBILDUNG_SCHWERPUNKT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Die molekulare Allergiediagnostik sucht gezielt nach einzelnen Allergenkomponenten. Der Vorteil: Das Sensibilisierungsprofil eines Patienten kann genau beurteilt werden. Das ist besonders bei komplexen Fällen hilfreich. Derzeit sind bereits mehr als 100 Allergenkomponenten kommerziell verfügbar, und die Bestimmung ist sogar mit Kapillarblut möglich.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbildung 1

Literatur

  1. Piquet, C.v. Allergie. Münchner Medizinische Wochenschrift, 1906: p. 1457.

  2. Johansson, S.G., The discovery of immunoglobulin E. Allergy Asthma Proc 2006. 27(2 Suppl 1): p. S3–6.

    CAS  PubMed  Google Scholar 

  3. Wen, J. et al. The potential of Bet v1 homologues, a nuclear multigene family, as phylogenetic markers in flowering plants. Mol Phylogenet Evol 1997. 8(3): p. 317–33.

    Article  CAS  PubMed  Google Scholar 

  4. Canonica, G.W. et al., A WAO - ARIA - GA(2) LEN consensus document on molecularbased allergy diagnostics. World Allergy Organ J 2013. 6(1): p. 17.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Eller, E. und Bindslev-Jensen, C. Clinical value of component-resolved diagnostics in peanut-allergic patients. Allergy 2013. 68(2): p. 190–4.

    Article  CAS  PubMed  Google Scholar 

  6. Masthoff, L.J. et al. Sensitization to Cor a 9 and Cor a 14 is highly specific for a hazelnut allergy with objective symptoms in Dutch children and adults. J Allergy Clin Immunol 2013. 132(2): p. 393–9.

    Article  CAS  PubMed  Google Scholar 

  7. Lange, L. Molekulare Diagnostik bei Allergie gegen Schalenfrüchte. Allergo J 2012. 21(7): p. 398–402.

    Article  Google Scholar 

  8. Valenta, R. et al. The recombinant allergenbased concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999. 29(7): p. 896–904.

    Article  CAS  PubMed  Google Scholar 

  9. Schmid-Grendelmeier, P. Recombinant allergens. For routine use or still only science? Hautarzt 2010. 61(11): p. 946–53.

    Article  CAS  PubMed  Google Scholar 

  10. Jappe, U. Molekulare Allergiediagnostik: Entwicklung und Bedeutung für die klinische Praxis. Allergologie 2013. 36(8): p. 327–349.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Thermo Fisher Scientific, Phadia GmbH, Munzingerstr. 7, D-79111, Freiburg, Deutschland

    Johannes Huss-Marp (Medical Director Deutschland, Österreich, Schweiz, ImmunoDiagnostics)

  2. Thermo Fisher Scientific, Freiburg, Deutschland

    Ina Schäffner

Authors
  1. Johannes Huss-Marp
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ina Schäffner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Johannes Huss-Marp.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huss-Marp, J., Schäffner, I. Das leistet die molekulare Allergiediagnostik. MMW - Fortschritte der Medizin 156, 45–47 (2014). https://doi.org/10.1007/s15006-014-2772-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-014-2772-9

Keywords - Molecular allergy diagnostics

Search

Navigation